Publication for STAT1 and GBP5
| Species | Symbol | Function* | Entrez Gene ID* | Other ID | Gene coexpression |
CoexViewer |
|---|---|---|---|---|---|---|
| hsa | STAT1 | signal transducer and activator of transcription 1 | 6772 | [link] | ||
| hsa | GBP5 | guanylate binding protein 5 | 115362 |
| Pubmed ID | Priority | Text |
|---|---|---|
| 26374119 | 0.96 | GBP5, STAT1, STAT2, and IFN-induced proteins with tetratricopeptide repeats (IFITs). |
| 26836588 | 0.96 | STAT1 via STX11 and GBP5, while the second pathway, TRIM22 SNX10 CYBB DRAM1 NOD2, contains the known VEOIBD gene CYBB (Figure 2B). |
| 31784594 | 0.96 | GBP5, GBP1, GBP2, OAS3, STAT1, STAT2 and TAP1) only displayed a significant effect upon treatment (Fig. S5). |
| 28264810 | 0.95 | GBP5, PDL1, PDL2, and STAT1. |
| 0.92 | GBP5, PSMB9, and STAT1, are also identified as signature genes for the basal immune-activated (BILA) subgroup of TNBC patients. | |
| 26362649 | 0.95 | STAT1, IRF1, GBP1, GBP5 and IDO1. |
| 29176033 | 0.95 | STAT1, three guanylate-binding proteins (GBP1, GBP4, and GBP5), and three 2'5'-oligoadenylate synthetases (OAS1, OAS2, and OAS3). |
| 24703167 | 0.94 | GBP5, IFI44, IFI44L, IFIH1, IFIT1, IFIT2, IFIT3, IFIT5, IFITM3, OAS1, OAS2, and STAT1). |
| 32012164 | 0.94 | GBP5), followed by STAT1 and IRF1, which are key TFs for IFN-gamma activation and type 1 interferon signaling (Fig 5B and S12-S14 Figs). |
| 30202120 | 0.93 | STAT1, GBP5, GBP1, EPSTI1 and IFITM3. |
| 0.80 | STAT1, GBP5, GBP1, EPSTI1, and IFITM3) shared by females and males in response to vaccination. | |
| 30221738 | 0.93 | GBP5, IFIH1, IFIT2, IFIT3 and STAT1. |
| 0.82 | signal transducer and activator of transcription (STAT)1 (degree=41), guanylate-binding protein (GBP)1 (degree=35), GBP5 (degree=35), C-X-C motif chemokine 10 (CXCL10; degree=35), interferon-induced protein with tetratricopeptide (IFIT)2 (degree=32), interferon regulator factor (IRF)7 (degree=32), IFIT3 (degree=32), ubiquitin-like protein ISG15 (ISG15; degree=31), IRF1 (degree=31) and interferon-induced helicase C domain-containing protein 1 (IFIH1; degree=2; Fig. 2). | |
| 26469538 | 0.92 | GBP5, GBP2, TAP1, STAT1, STAT2, IFI35, TAP2, CD274, CXCL10, IFIT5) in infected tissue (Supplementary Table ST1). |
| 28433800 | 0.90 | GBP5, CXCL11, MMP3, FST, BATF2, SPP1, SH2D5, CXCL9, IFIT3, SERPINE1, GALNT6, FOXL2, PDPN, ITGA3, VEGFC, STAT1, LY6K, KLF7, SOX9 and CD274. |
| 25961742 | 0.88 | GBP5, CXCL10, CXCL13, LAMP3, STAT1, CTLA4, TOP2A, LCK. |
| 28805681 | 0.82 | GBP5, IFI44, GMPR, and NT5C3 for GTP catabolism and cytokine processing; STAT1 for amplification of autocrine ISG expression, as well as many other antiviral factors. |
| 32265897 | 0.81 | STAT1 and GBP5 but not in association with IFNgamma or IFI30 (Figure 3E), though IFI30 is strongly expressed in normal tissue (Table S9). |
| 30032138 | 0.80 | STAT1, STAT2, and STAT3 (Fig. 3b-d), as well as the ISGs (ISG15, ISG56, OAS-1, OAS-2, MxA, MxB, and GBP5; Fig. 4); and (C) TLR3 activation had little effect on the expressions of IL-10, IL-22 and IL-26, all of which share IL-10Rbeta, a subunit receptor for IFN-lambdas (data not shown). |
| 30131873 | 0.78 | GBP5, TAP1, PARP9, NMI, DTX3L, HLA-E and PSMB9 were commonly increased by WT STAT1 as well as both mutants. |
| 20725040 | 0.67 | GBP5, STAT1, GBP2, TAP1, STAT1, STAT2, IFI35, TAP2, CD274, SOCS1, CXCL10, IFIT5). |
| 29567951 | 0.60 | STAT1, CXCL10, HCK, CCL5, IRF7, CXCL9, GBP5, PLEK, CD163, SMAD4, CASP1, CDH1, GBP2, GBP1, BIRC5, GZMB, C1QB, CALM1 and C1QA. |
The preparation time of this page was 0.1 [sec].
